Drug
Xenon
Xenon: highest development phase Phase 3, developed by Orion Corporation. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Orion Corporation
Trials
| Drug | Phase | Indication |
|---|---|---|
| Xenon NCT01294163 | Phase 3 | Coronary Artery Disease |
Latest
No recent events.
Follow Xenon on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.